Table 1. Patient Demographics.
| Acute Kidney Injury Stage | Stage 0 | Stage 1 | Stage 2/3 | HD |
|---|---|---|---|---|
| n | 65 | 41 | 20 | 24 |
| APACHEII | 13.8 ± 7.5 | 18.5 ± 7.9 | 22.8 ± 8.3 | 17.7 ± 5.0 |
| S. aureus | 20.0% | 9.8% | 10.0% | 33.3% |
| S. pneumoniae | 21.5% | 19.5% | 35.0% | 8.3% |
| E. coli | 12.3% | 14.6% | 5.0% | 4.2% |
| Other Etiologic Agent1 | 12.3% | 22.0% | 20.0% | 33.3% |
| Unidentified Etiologic Agent | 10.8% | 12.2% | 25.0% | 4.2% |
| No Infection | 23.1% | 22.0% | 5.0% | 16.7% |
| Death | 20.0% | 29.3% | 40.0% | 12.5% |
| Age | 59.6 ± 17.7 | 64.9 ± 16.6 | 67.4 ± 18.6 | 51.6 ± 12.1 |
| Gender (male) | 50.8% | 61.0% | 45.0% | 62.5% |
| Race (B/W/O) | 40/23/2 | 27/11/3 | 11/6/3 | 22/2/0 |
| Liver disease | 6.2% | 7.3% | 20.0% | 4.2% |
| Heart failure | 6.2% | 9.8% | 15.0% | 4.2% |
| Chronic lung disease | 30.8% | 29.3% | 30.0% | 20.8% |
| Malignancy | 13.8% | 19.5% | 5.0% | 8.3% |
1
Includes all identified etiologic agents other than S. aureus, S. pneumoniae, or E. coli
Data presented as mean ± standard deviation
Black, white, other (B, W, O)